Showing results (221-230 of 419) with videos related to
Sort By:
Pageof 42
Critical Reviews in Oncology/Hematology|November 10, 2024
KRAS mutations in advanced non-small cell lung cancer: From biology to novel therapeutic strategiesLuigi Liguori, Fabio Salomone, Angela Viggiano, et al.Cancer Immunology, Immunotherapy : CII|December 3, 2008
Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cellsTakashi Mine, Satoko Matsueda, Yufeng Li, et al.Journal of the National Cancer Institute|June 5, 2020
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant TherapyTheodoros Michelakos, Lei Cai, Vincenzo Villani, et al.Cancer Research|November 5, 2002
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicityDaniela Pende, Paola Rivera, Stefania Marcenaro, et al.Blood|July 28, 2005
The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactionsGiuseppe Sconocchia, Michelle Lau, Maurizio Provenzano, et al.Molecular Cancer Therapeutics|November 13, 2008
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factorsYasufumi Goto, Takaaki Arigami, Minoru Kitago, et al.Oncotarget|April 22, 2017
Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinomaLei Cai, Theodoros Michelakos, Cristina R Ferrone, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Allorecognition of an HLA-A*01 aberrant allele by an HLA identical family member carrying the HLA-A*0101 alleleIngrid Almeciga, Zhigang Charles Wang, Joaquin Zúñiga, et al.The Journal of Biological Chemistry|September 19, 2015
Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapyChien-Chung Chang, Giuseppe Pirozzi, Shao-Hsuan Wen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cellsMichael S Leibowitz, Raghvendra M Srivastava, Pedro A Andrade Filho, et al.Pageof 42